What our clients
actually say

"We had collected years of clinical data but had no clear picture of what it could support analytically. The Readiness Assessment was genuinely eye-opening — not in the way we expected, but in the way we needed. The team was candid about what was and wasn't workable, and that saved us from committing significant internal resources to a dead end."

"The AI advisory helped us ask much better questions during vendor demonstrations. We had been evaluating a clinical decision support tool largely on its interface — after working through the governance and workflow considerations with Mirova Health, we realised we had been looking at the wrong things. The timeline ran slightly longer than expected, but the written outputs were worth it."

"The readmission risk modelling project was structured from the very first meeting around what was clinically meaningful — not what would produce the most impressive metric. The final report was clear enough that I could present it to our medical advisory board without translation. That's rare."

"What I valued most was the willingness to say when something wasn't worth doing. We had a proposed use case around bed occupancy prediction that Mirova Health assessed as unlikely to add value given our data structure. That kind of direct assessment — backed by reasoning — is not common in this space."

"We engaged Mirova Health for the data readiness assessment before proceeding with a larger analytics programme. The assessment was thorough and identified two significant data quality issues we had not noticed internally — both of which would have affected any modelling work downstream. Recommendations were practical and prioritised well."

"The governance component of the advisory was particularly useful. We had read the MOH guidelines but were uncertain how they applied to our specific procurement situation. The written guidance gave us a clear framework we could share directly with our legal and compliance teams."